Every early-stage founder eventually hits the same fork in the road. You have a lead angel ready to wire money, but the round is not priced, and someone asks the question that stalls the whole thing: SAFE or convertible note? Both let you raise now and settle valuation later, yet they behave very differently on your cap table, in your tax file, and in the room when your Series A lead runs diligence. This guide walks a US founder through the real trade-offs between a post-money SAFE and a convertible note, so the instrument you sign matches the raise you are actually running.
The stakes are higher than the paperwork suggests. The instrument you choose today quietly shapes how much of your company you still own after the priced round, and a choice made for convenience in week one can cost real ownership at Series A. So it pays to understand what each document does before you countersign.
What a SAFE and a convertible note actually are
A SAFE, short for Simple Agreement for Future Equity, is a contract that gives an investor the right to receive stock in a future priced round. It is not a loan. There is no interest, no maturity date, and no promise to repay anything. Y Combinator introduced the instrument in 2013 to strip the debt features out of early fundraising, and the post-money SAFE it released in 2018 became the market default. The word "post-money" refers to the moment the investor's ownership percentage is calculated, which lets both sides see exactly what slice the check buys at signing.
A convertible note is a short-term debt instrument that converts into equity when you raise a priced round. It carries an interest rate, usually in the range of six to eight percent, and a maturity date, typically eighteen to twenty-four months out. Until conversion, it sits on your balance sheet as a liability, and the accrued interest converts into equity alongside the principal. In practice the two instruments share the same headline levers, a valuation cap and sometimes a discount, but the note wraps them in the machinery of a loan while the SAFE does not.
That single distinction, debt versus a contractual right to future equity, drives almost everything else. It changes who bears risk if the company stalls, how the instrument reads to a later investor, and what your accountant has to record. Founders who treat the two as interchangeable tend to discover the difference at the worst possible moment.
Legal framework for US early-stage instruments
Both instruments are securities under federal law, which means issuing either one is a regulated event even when the paperwork feels informal. When you sell a SAFE or a note, you are relying on an exemption from registration under the Securities Act of 1933, most commonly Regulation D, Rule 506(b) or 506(c). Skipping the exemption analysis is not a formality you can clean up later: an unregistered, non-exempt sale of securities can give the investor rescission rights, meaning they can demand their money back. Most 506(b) raises also require a Form D filing with the SEC within fifteen days of the first sale, plus any state "blue sky" notice filings where your investors sit. The Securities and Exchange Commission publishes plain-language guidance on these exemptions, and the SEC overview of Regulation D exempt offerings is the authoritative starting point before you circulate any term sheet.
The instruments diverge sharply once you leave securities law and look at contract and corporate mechanics. A convertible note is governed by the note's own terms plus general contract law, and because it is genuine debt, an unpaid note at maturity can in theory push a company toward default. A SAFE has no maturity, so it simply waits on the cap table until a triggering event, usually your first priced financing, an acquisition, or dissolution. Both convert according to a defined formula tied to the valuation cap or discount, and both should track your state's corporate law on issuing the underlying stock, since the shares themselves are created under the Delaware General Corporation Law or your state's equivalent when the round finally prices.
There is also a securities-law wrinkle specific to the SAFE that catches founders off guard. The SEC has publicly cautioned that a SAFE is not automatically as simple as its name implies, and that it does not always behave like the safe savings vehicle the acronym suggests. Treating it as a fill-in-the-blank form, without confirming your exemption and your cap table math, is exactly the shortcut that creates problems in diligence.
How each instrument hits your cap table and your dilution
The most consequential difference between the two shows up in dilution, and it is where post-money SAFEs earn both their popularity and their reputation. Under a post-money SAFE, the investor's ownership is fixed relative to the fully diluted capitalization measured after all SAFE money is counted. An investor who puts in two hundred thousand dollars on a four million dollar post-money cap owns exactly five percent at signing, and knows it. That clarity is the feature. The catch is that when you stack several post-money SAFEs before a priced round, each one locks in its own percentage, and the combined dilution falls almost entirely on the founders rather than being shared across the investor pool the way older pre-money SAFEs worked.
Convertible notes distribute dilution more like the pre-money model, and they add accrued interest to the conversion. That interest buys the noteholder slightly more equity than the cash alone would, which is the price you pay for the debt structure. The trap with either instrument is the same: founders who raise round after round without modeling the cumulative conversion walk into their Series A owning far less than they assumed. In practice, most experienced founders build a fully diluted, as-converted cap table before signing each new instrument, treating outstanding SAFEs and notes as if they had already converted. Skipping that exercise is the single most common reason a founder is blindsided by their own ownership number when the priced round finally closes.
If you are formalizing equity splits and vesting at the same time you start raising, it is worth reading how a co-founder agreement handles vesting and IP assignment so the SAFE or note you issue sits on a clean foundation. A messy founder cap table makes every later conversion harder to model.
Which instrument fits your 2026 raise
For most US startups raising their first outside capital, the honest answer is that a post-money SAFE is the default, and you need a specific reason to deviate. It is faster to close, since it is a short standardized document rather than a negotiated ten-page note, and angel investors generally expect it. There is no maturity clock ticking, no interest accruing, and no repayment risk hanging over a company that hits a slow quarter. When your investor simply wants early exposure at a capped valuation and trusts you to reach a priced round, the SAFE removes friction that a note would add for no benefit.
The note earns its keep in narrower situations. Some investors, particularly outside the classic software world, still prefer the creditor protections that debt provides, including the leverage a maturity date creates if the company drifts. In certain sectors, medical devices, biotech, and energy among them, convertible notes remain far more common than in SaaS, where founders and angels treat the SAFE as standard. A note can also make sense when an investor wants the modest extra return that accruing interest delivers, or when the parties genuinely expect a priced round on a defined timeline and want a deadline that keeps everyone honest.
The deciding factors, in plain terms, come down to speed, investor expectation, and appetite for a deadline. If you want to close this week with a familiar form your angels have signed before, reach for the SAFE. If your investor insists on debt-style protection or your sector leans that way, the note is not a mistake. What is a mistake is defaulting to whichever template you found first without asking which structure your specific investors actually want. When the round eventually prices, both instruments feed into a shareholder agreement covering drag-along and board control, so it helps to think one step ahead about the equity documents your conversion will trigger.
Generating the right instrument on Captain.Legal
Once you know which structure fits, producing a clean, exemption-aware document is the straightforward part. Captain.Legal's post-money SAFE template modeled on the Y Combinator form walks you through the variables that actually matter, your company name and state of incorporation, the purchase amount, the valuation cap, and whether you are including a discount or a most-favored-nation clause. The document is drafted against the Securities Act of 1933 and Reg D Rule 506, and it comes with Form D guidance and an optional pro-rata side letter, so you are not left guessing about the federal filing that follows the signature.
If your raise calls for debt instead, the convertible note agreement built for Regulation D covers the levers a note adds on top of the SAFE, the interest rate, the maturity date, and the qualified-financing threshold that triggers conversion. You choose the terms, the template assembles the language, and you download a signature-ready file in both editable Word and clean PDF. That format matters more than it sounds: keeping an editable Word version means you can adjust a cap or a closing date without retyping the whole instrument, and the PDF gives you a fixed record to countersign and store. Founders who want the surrounding corporate documents in place can pair either instrument with corporate bylaws drafted to state corporation law so the company issuing the securities is properly organized from day one.
Common mistakes founders make with SAFEs and notes
The first and most expensive mistake is not modeling cumulative dilution. Founders sign one post-money SAFE, feel fine about it, then sign three more over eighteen months without ever building a combined as-converted cap table, and arrive at Series A having sold far more of the company than they realized. The second is treating the instrument as a private handshake and ignoring securities compliance. A SAFE or note is a security, and skipping the Reg D exemption analysis or forgetting the Form D filing turns a routine raise into a legal exposure that surfaces precisely when a lead investor's counsel starts diligence.
A third recurring error is misreading the debt in a convertible note. Founders sometimes forget that interest accrues and converts, or they let a maturity date pass without addressing it, which technically puts the company in default even when the investor never intended to call the loan. Fourth, founders mix incompatible terms across instruments, issuing a note with a most-favored-nation clause and then a later SAFE on better terms, without checking whether the MFN clause quietly rewrites the earlier deal. Finally, many founders sign with a valuation cap set on instinct rather than analysis, either so high it gives the investor almost nothing or so low it hands away an outsized stake. Each of these is avoidable with an hour of modeling and a document that surfaces the right variables before you commit. Getting the confidentiality piece right early also matters, so if you are sharing sensitive numbers with prospective investors, a confidentiality and IP assignment agreement protects the disclosures you make during the raise.
Frequently asked questions
Is a SAFE legally binding without a lawyer?
A SAFE is a binding contract the moment both parties sign it, regardless of whether an attorney was involved. What makes it enforceable is proper execution and a valid securities exemption, not a lawyer's letterhead. That said, the binding nature cuts both ways: an ambiguous cap, a missing Form D filing, or a conflict with an earlier instrument can create real problems even on a signed document. A well-drafted template that already accounts for the Securities Act of 1933 and Reg D Rule 506 gives you an enforceable instrument, and you can generate a convertible note or SAFE from the business documents library without retaining counsel for a standard raise.
What is the main difference between a post-money SAFE and a convertible note?
The core difference is debt. A convertible note is a loan that accrues interest, usually six to eight percent, and carries a maturity date, generally eighteen to twenty-four months, after which repayment can technically be demanded. A post-money SAFE is not debt at all; it is a contractual right to future equity with no interest, no maturity, and no repayment obligation. The SAFE also fixes the investor's ownership percentage at signing based on the post-money cap, while the note's interest keeps accruing until conversion, giving the noteholder slightly more equity than the cash alone.
Can I download a SAFE or convertible note in Word and PDF?
Yes. Both instruments generate in editable Word format and as a clean, signature-ready PDF. The Word file is the one you will use during negotiation, since it lets you adjust a valuation cap, a purchase amount, or a closing date without retyping the document. The PDF is your fixed record for signing and storage. Keeping both matters, because an early-stage raise almost always involves a small change between the first draft and the executed version, and starting from a locked PDF alone forces you back to square one every time a term moves.
How long does a convertible note last before it converts?
A convertible note runs until its maturity date, most commonly eighteen to twenty-four months from issuance, or until a qualified priced financing triggers conversion earlier. If a priced round happens first, which is the intended outcome, the note converts into equity at the cap or discount and the maturity date never becomes an issue. If maturity arrives before any priced round, the note is technically due, and the parties usually negotiate an extension because forcing repayment is bad for both sides. A post-money SAFE, by contrast, has no maturity and simply waits on the cap table indefinitely.
Do I have to file anything with the SEC after issuing a SAFE?
In most cases, yes. If you rely on Regulation D, Rule 506, you generally must file a Form D with the SEC within fifteen days of your first sale, and you may owe state blue sky notice filings where your investors are located. The filing is short and does not require SEC approval, but missing it can jeopardize the exemption you are relying on. This is one of the steps founders most often overlook when they treat a SAFE as an informal document, and it is precisely the kind of detail a later investor's diligence will check.
Which is better for founders, a SAFE or a note?
Neither is universally better; the right choice depends on your investors and your sector. A post-money SAFE is faster, carries no debt risk, and is the expected instrument for most software and consumer angel raises, which is why it dominates. A convertible note offers creditor protections and a small interest return that some investors, particularly in biotech, medical devices, and energy, still prefer. The better instrument is the one your actual investors will sign without friction, so the practical move is to ask what they expect before you pick a template.